CNE100003R98
CNE100003R98
BIO THERA SOLUTIONS LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.99B EUR | 6.96B EUR | 8.99B EUR |
Enterprise Value | 8.49B EUR | 7.53B EUR | 9.52B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -28.38x | -- | -- |
Price to Sales | 7.9x | 6.93x | 9.51x |
Price to Book | 64.55x | 56.19x | 40.11x |
EV/Revenue | 8.4x | 7.49x | 10.08x |
EV/EBITDA | -22.35x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -3.05% | -3.05% | -2.24% |